Screening a protein kinase inhibitor library against Plasmodium falciparum.

Malar J 2017 11 7;16(1):446. Epub 2017 Nov 7.

Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, DD1 5EH, UK.

Background: Protein kinases have been shown to be key drug targets, especially in the area of oncology. It is of interest to explore the possibilities of protein kinases as a potential target class in Plasmodium spp., the causative agents of malaria. However, protein kinase biology in malaria is still being investigated. Therefore, rather than assaying against individual protein kinases, a library of 4731 compounds with protein kinase inhibitor-like scaffolds was screened against the causative parasite, Plasmodium falciparum. This approach is more holistic and considers the whole kinome, making it possible to identify compounds that inhibit more than one P. falciparum protein kinase, or indeed other malaria targets.

Results: As a result of this screen, 9 active compound series were identified; further validation was carried out on 4 of these series, with 3 being progressed into hits to lead chemistry. The detailed evaluation of one of these series is described.

Discussion: This screening approach proved to be an effective way to identify series for further optimisation against malaria. Compound optimisation was carried out in the absence of knowledge of the molecular target. Some of the series had to be halted for various reasons. Mode of action studies to find the molecular target may be useful when problems prevent further chemical optimisation.

Conclusions: Progressible series were identified through phenotypic screening of a relatively small focused kinase scaffold chemical library.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12936-017-2085-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678585PMC
November 2017
25 Reads

Publication Analysis

Top Keywords

protein kinase
16
protein kinases
12
plasmodium falciparum
8
series identified
8
molecular target
8
protein
6
series
6
kinase
5
validation carried
4
compound series
4
identified validation
4
series progressed
4
carried series
4
hits lead
4
series describeddiscussion
4
describeddiscussion screening
4
screening approach
4
evaluation series
4
detailed evaluation
4
lead chemistry
4

References

(Supplied by CrossRef)

AH Fairlamb et al.
Nat Microbiol 2016

B Blasco et al.
Nat Med 2017

D Jirage et al.
Infect Disord Drug Targets 2010

LH Miller et al.
Nat Med 2013

Anamika et al.
Proteins 2005

P Ward et al.
BMC Genomics 2004

IS Lucet et al.
Future Med Chem 2012

C Doerig et al.
BBA-Proteins Proteomics 2004

CW McNamara et al.
Nature 2013

T Paquet et al.
Sci Transl Med 2017

L Solyakov et al.
Nat Commun 2011

Similar Publications